Search Results - "Veraar, Kimberley A. M."

Intrinsic carnosine metabolism in the human kidney by Peters, Verena, Klessens, Celine Q. F., Baelde, Hans J., Singler, Benjamin, Veraar, Kimberley A. M., Zutinic, Ana, Drozak, Jakub, Zschocke, Johannes, Schmitt, Claus P., de Heer, Emile

“…Histidine-containing dipeptides like carnosine and anserine have protective functions in both health and disease. Animal studies suggest that carnosine can be…”
Get full text

Four‐jointed knock‐out delays renal failure in an ADPKD model with kidney injury by Formica, Chiara, Happé, Hester, Veraar, Kimberley AM, Vortkamp, Andrea, Scharpfenecker, Marion, McNeill, Helen, Peters, Dorien JM

“…Autosomal Dominant Polycystic Kidney Disease is characterised by the development of fluid‐filled cysts in the kidneys which lead to end‐stage renal disease…”
Get full text

An autopsy study suggests that diabetic nephropathy is underdiagnosed by Klessens, Celine Q F, Woutman, Tess D, Veraar, Kimberley A M, Zandbergen, Malu, Valk, Elisabeth J J, Rotmans, Joris I, Wolterbeek, Ron, Bruijn, Jan A, Bajema, Ingeborg M

“…The reported prevalence of diabetic nephropathy (DN) among patients with diabetes varies widely. Most studies use the presence of microalbuminuria for clinical…”
Get more information

In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease by Booij, Tijmen H, Leonhard, Wouter N, Bange, Hester, Yan, Kuan, Fokkelman, Michiel, Plugge, Anna J, Veraar, Kimberley A M, Dauwerse, Johannes G, van Westen, Gerard J P, van de Water, Bob, Price, Leo S, Peters, Dorien J M

“…Abstract Polycystic kidney disease (PKD) is a prevalent genetic disorder, characterized by the formation of kidney cysts that progressively lead to kidney…”
Get full text

Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease by Zittema, Debbie, Versteeg, Irina B, Gansevoort, Ron T, van Goor, Harry, de Heer, Emile, Veraar, Kimberley A M, Peters, Dorien J M, Meijer, Esther

“…In autosomal dominant polycystic kidney disease, renoprotective treatment with a vasopressin V2 receptor antagonist (V2RA) is given in a fixed dose (FD)…”
Get more information